by Virtus | Jun 6, 2026 | Early-Stage Respiratory Drug Development
Asthma drug development plays a critical role in improving outcomes for millions of people living with asthma worldwide. Despite significant advances in treatment, asthma remains a complex and highly variable respiratory disease that continues to drive demand for...
by Virtus | Jun 6, 2026 | Respiratory Preclinical Research
Respiratory disease models are essential tools in preclinical respiratory research, allowing scientists to investigate disease mechanisms, evaluate therapeutic candidates and generate data that supports respiratory drug development. From asthma and COPD to viral...
by Virtus | Jun 6, 2026 | Early-Stage Respiratory Drug Development
Respiratory drug development is a complex process that transforms scientific discoveries into therapies for patients with respiratory diseases. From asthma and COPD to viral respiratory infections, developing new respiratory medicines requires a combination of...
by Virtus | Jun 6, 2026 | Respiratory Preclinical Research
Preclinical respiratory models play a vital role in respiratory drug development by allowing researchers to evaluate therapeutic candidates before clinical trials begin. These models are used throughout respiratory preclinical research to investigate disease...
by Virtus | May 3, 2026 | Viral & Rhinovirus Models
Rhinovirus vs RSV vs influenza preclinical models are commonly compared in respiratory preclinical research because each viral system represents a different aspect of respiratory disease. Viral challenge preclinical studies use these models to evaluate antiviral...
